The FDA 'Bad Ad' Program — Us Vs. Them
Citing a limited ability to identify violative pharmaceutical advertising and promotional activities, the Food and Drug Administration has announced the launch of its "Bad Ad" Program. The program encourages health care...To view the full article, register now.
Already a subscriber? Click here to view full article